Medtech Insight’s MTI 100 comprises a set of industry league tables providing US dollar rankings of medtech companies according to their overall annual medical device and IVD revenues where appropriate, and product sector-specific revenues where possible.
Medtech
This year's top 100 ranking of global medtechs by revenue shows how industry leaders are aligning innovation with market trends to meet user and patient needs, while also managing their portfolios for growth.
• By
The Top 100 ranking of global medtechs by revenues for 2023 illustrated how the leaders continue to tailor innovation to users and patients according to market trends while driving portfolio management for growth.
• By
Meron Mathias is vice president of CSR and sustainability at Thermo Fisher, whose specialty diagnostics division makes it the fifth leading player by revenues in the global IVD industry. In this podcast, she reflects on Thermo Fisher’s early commitment to ESG and sustainability reporting, its Scope 1, 2 and 3 targets and how regulation is moving industry towards a mandatory disclosure landscape.
• By
Health authorities around the world are being advised to mitigate the relentless rise in the long-term costs of stroke, set to top $1.5tn within a generation. Wider availability of mechanical thrombectomy will help address providers’ and patients’ needs, Royal Philips CMO Carla Perón explained in an interview with In Vivo.
• By
Josef Coresh, founding director of the Optimal Aging Institute at NYU Grossman School of Medicine, talks about his ongoing research to mark Alzheimer’s and Brain Awareness Month.